Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Real-World Data on Safety and Efficacy of Venetoclax-Based Regimens in Relapsed/Refractory t[11;14] Multiple Myeloma

Diana Basali, MD, Rajshekhar Chakraborty, MD, Lisa Rybicki, MS, Nathaniel Rosko, PharmD, Janice Reed, RN, Mary Ann Karam, RN, Kristen Schlueter, RN, Hayley Dysert, Beth M. Faiman, PhDCNP, Kimberly Hamilton, APRN/PA, Matt Kalaycio, MD, Jason Valent, MD

Blood (2019) 134 (Supplement_1): 5566.

https://doi.org/10.1182/blood-2019-129002

Published: 2019

Journal Articles

Assessing the Safety and Efficacy of Converting Adults with Sickle Cell Disease from Full Agonist Opioids to Buprenorphine

Mandy David, PA-C, MPH, Christopher Carroll, MD, Ashley Lauriello, NP, Benjamin Salzberg, Sophie Lanzkron, MD MHS

Blood (2018) 132 (Supplement 1): 856.

https://doi.org/10.1182/blood-2018-99-111435

Published: 2018

Journal Articles

Safety and Efficacy of Fecal Microbiota Transplantation for Recurrent Clostridium Infection in Patients with Hematologic Malignancies

Mehrdad Hefazi, MD, Mrinal M Patnaik, MBBS, William J Hogan, MBChB, Mark R Litzow, MD, Darrell S Pardi, MD, Sahil Khanna, MBBS

Blood (2016) 128 (22): 3599.

https://doi.org/10.1182/blood.V128.22.3599.3599

Published: 2016

Journal Articles

Transformation of Follicular Lymphoma to a High Grade B-Cell Lymphoma with MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia

David M Aboulafia, MD, Alina Bischin, Russell K. Dorer, MD PhD

Blood (2016) 128 (22): 5421.

https://doi.org/10.1182/blood.V128.22.5421.5421

Published: 2016

Journal Articles

Neutropenic Enterocolitis: Clinical Features and Outcomes

Delphine Lebon, MD, Emmanuel Canet, MD, Lucie Biard, MD, David Schnell, MD, Camille Roussel, Sophie Buyse, Benoit Schlemmer, MD PhD, Elie Azoulay, MD PhD

Blood (2014) 124 (21): 5984.

https://doi.org/10.1182/blood.V124.21.5984.5984

Published: 2014

Journal Articles

Successful Engrafment After HLA Identical Granulocyte Transfusion As Support Therapy in a Septic Shock Patient with Acute Lymphoblastic Leukemia

Roberto Ovilla, MD, Claudia Barrera-Carmona, MD, Nicolas Guzman-Bouilloud, MD, Elizabeth Buganza-Torio, MD, Rosa Jimenez-Alvarado, MD, Claudia Monreal-Alcantara, MD

Blood (2012) 120 (21): 4507.

https://doi.org/10.1182/blood.V120.21.4507.4507

Published: 2012

Journal Articles

Telangiectasia Macularis Eruptiva Perstans: Report of Three Cases

Gizem Tumer, MD, Tiffany Jow, BS, W. Clark Lambert, MD, PhD

Blood (2011) 118 (21): 5176.

https://doi.org/10.1182/blood.V118.21.5176.5176

Published: 2011

Journal Articles

Safety of Defibrotide (DF) In Stem Cell Transplant (SCT) Patients (Pts).

Selim Corbacioglu, MD, Enric Carreras, MD, PhD, Dietger W Niederwieser, MD, Marco Sardella, PharmD, Margaret Hoyle, Robin Hume, M.S., Joseph Massaro, Ph.D., Alison L. Hannah, MD, Massimo Iacobelli, MD, Paul G Richardson, Defibrotide Study Group

Blood (2010) 116 (21): 3482.

https://doi.org/10.1182/blood.V116.21.3482.3482

Published: 2010

Journal Articles

Change in Liver Iron Concentration (LIC), Serum Ferritin (SF) and Labile Plasma Iron (LPI) Over 1 Year of Deferasirox (DFX/Exjade ® ) Therapy in a Cohort of Myelodysplastic Patients

Peter L Greenberg, Charles Schiffer, Charles A Koller, Tara Glynos, Carole Paley

Blood (2008) 112 (11): 5083.

https://doi.org/10.1182/blood.V112.11.5083.5083

Published: 2008

Journal Articles

A Phase I Study of 90 Y-Ibritumomab-Tiuxetan ( 90 Y-It) in Children with Recurrent/Refractory CD20 Positive Lymphoma: A Cog Phase I Consortium Study.

Mitchell S. Cairo, MD, Erin Cooney, CPNP, Mark Krailo, PhD, Richard Belanger, MS, CHP, Sherrie L. Perkins, MD, PhD, Rashid Fawwaz, MD, Anne Angiolillo, MD, Peter Adamson, MD

Blood (2005) 106 (11): 2448.

https://doi.org/10.1182/blood.V106.11.2448.2448

Published: 2005

Journal Articles

The HIV-Protease Inhibitor Ritonavir(Norvir®) Is Active Against Human AML Blasts In Vitro and In Vivo and Has Synergistic Cytotoxic Activity with the Proteaseome Inhibitor Bortezomib (Velcade®).

Christoph Driessen, Müller-Ide Hendrik, Gogel Jeanette, Kraus Marianne, Kanz Lothar, Rückrich Thomas

Blood (2005) 106 (11): 2464.

https://doi.org/10.1182/blood.V106.11.2464.2464

Published: 2005

Journal Articles

Clinical Significance of Positive Clostridium Difficile (CD) Toxin in the Stool of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Yoshiki Terada, Yasushi Onishi, Sung-Won Kim, Masahiro Kami, Shin-ichiro Mori, Yuji Heike, Yoichi Takaue, Ryuji Tanosaki

Blood (2004) 104 (11): 5078.

https://doi.org/10.1182/blood.V104.11.5078.5078

Published: 2004

Journal Articles

Inhibitor of Human Plasma Kallikrein DX-88 for the Treatment of Acute Attack in a Family with Hereditary Angioedema.

Ruby Anne E. Deveras, MD, Francisco Bracho, MD

Blood (2004) 104 (11): 4109.

https://doi.org/10.1182/blood.V104.11.4109.4109

Published: 2004

NARROW

Real-World Data on Safety and Efficacy of Venetoclax-Based Regimens in Relapsed/Refractory t[11;14] Multiple Myeloma

Assessing the Safety and Efficacy of Converting Adults with Sickle Cell Disease from Full Agonist Opioids to Buprenorphine

Safety and Efficacy of Fecal Microbiota Transplantation for Recurrent Clostridium Infection in Patients with Hematologic Malignancies

Transformation of Follicular Lymphoma to a High Grade B-Cell Lymphoma with MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia

Neutropenic Enterocolitis: Clinical Features and Outcomes

Successful Engrafment After HLA Identical Granulocyte Transfusion As Support Therapy in a Septic Shock Patient with Acute Lymphoblastic Leukemia

Telangiectasia Macularis Eruptiva Perstans: Report of Three Cases

Safety of Defibrotide (DF) In Stem Cell Transplant (SCT) Patients (Pts).

Change in Liver Iron Concentration (LIC), Serum Ferritin (SF) and Labile Plasma Iron (LPI) Over 1 Year of Deferasirox (DFX/Exjade ® ) Therapy in a Cohort of Myelodysplastic Patients

A Phase I Study of 90 Y-Ibritumomab-Tiuxetan ( 90 Y-It) in Children with Recurrent/Refractory CD20 Positive Lymphoma: A Cog Phase I Consortium Study.

The HIV-Protease Inhibitor Ritonavir(Norvir®) Is Active Against Human AML Blasts In Vitro and In Vivo and Has Synergistic Cytotoxic Activity with the Proteaseome Inhibitor Bortezomib (Velcade®).

Clinical Significance of Positive Clostridium Difficile (CD) Toxin in the Stool of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Inhibitor of Human Plasma Kallikrein DX-88 for the Treatment of Acute Attack in a Family with Hereditary Angioedema.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only